Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.44
27.01.21
€45.00
27.01.22
-4.29%
28.01.22

Could be worthwhile Investment >10% per year
azou 
27.01.21 50%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€67.80
23.01.21
€88.00
23.01.22
-26.99%
24.01.22

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
kostojunior 
23.01.21 80%
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
kostojunior 
23.01.21 80%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.14
09.01.22
-
09.01.23
-5.80%
23.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
09.01.22 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€49.60
10.01.22
€70.00
10.01.23
3.36%
22.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
10.01.22 80%
sell
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€123.30
17.08.21
-
17.08.22
-27.01%
12.01.22

DirectorDealer 
17.08.21 50%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€4.36
10.01.21
€6.00
10.01.22
-15.14%
11.01.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
10.01.21 60%
buy
4 SC AG

Start price
Target price
Perf. (%)
€2.11
10.01.21
€2.00
10.01.22
-29.15%
11.01.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Top 10 in its market
Known brand
kostojunior 
10.01.21 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.80
14.08.21
-
14.08.22
0.36%
04.01.22

Higher risks for its business
Increased challenges to pay loans and raise capital
SpringheelJack 
14.08.21 50%
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
melinda 
30.12.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.53
10.12.21
€70.00
10.12.22
1.21%
27.12.21

Undervalued
Risky Investment
phonebroker 
10.12.21 50%
buy
Formycon AG

Start price
Target price
Perf. (%)
€66.90
18.04.21
-
18.04.22
-16.59%
21.12.21

Could be worthwhile Investment >10% per year
Savour 
18.04.21 30%
sell
Merck KGaA

Start price
Target price
Perf. (%)
€144.40
25.03.21
€130.00
25.03.22
56.79%
14.12.21

Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
Snowman 
25.03.21 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
melinda 
12.10.21 50%
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€76.10
09.07.21
-
09.07.22
-25.49%
05.12.21

Mori8 
09.07.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
melinda 
18.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€47.19
26.08.21
-
26.08.22
5.16%
17.11.21

Mori8 
26.08.21 50%
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.38
26.11.20
-
16.11.21
198.22%
17.11.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
Amped 
26.11.20 0%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€16.50
11.11.21
-
11.11.22
0.61%
12.11.21

donglengcha 
11.11.21 50%
sell
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
shadow 
04.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€42.35
23.10.20
€54.00
04.11.21
17.72%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
23.10.20 50%
buy
Paion AG

Start price
Target price
Perf. (%)
€2.55
17.10.20
€5.00
04.11.21
-27.69%
05.11.21

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
kostojunior 
17.10.20 50%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€9.44
06.08.20
€12.00
04.11.21
-12.08%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Small cyclical dependencies
Schmiedseppe 
06.08.20 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€108.25
06.08.20
€130.00
04.11.21
-62.47%
05.11.21

tamam 
06.08.20 50%